iShares Evolved U.S. Innovative Healthcare ETF
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $319,787,000 last year. Net change in cash is therefore $905,000.
Cash Flow
| 2013 | 279.94M | -598.83M | 319.78M |
|---|
IEIH Cash Flow Statement (2013 – 2013)
| 2013 | |
|---|---|
Cash at beginning of period | 1.71M |
Operating activities | |
Net income | 172.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 123.56M |
Stock-based compensation expense | 5.94M |
| Deferred income tax benefit | 5.94M |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | -24.70M |
Inventories | 0 |
Accounts payable | 0 |
Cash generated by operating activities | 279.94M |
Investing activities | |
Purchases Of Investments | 0 |
Investments In Property Plant And Equipment | 0 |
Acquisitions Net | 0 |
Cash generated by investing activities | -598.83M |
Financing activities | |
Common Stock Issued | 0 |
Payments for dividends | -218.11M |
Repurchases of common stock | 0 |
Repayments of term debt | -457.64M |
Cash used in financing activities | 319.78M |
Net Change In Cash | 905K |
Cash at end of period | 2.61M |